Skip to main content
Premium Trial:

Request an Annual Quote

William Beltz, Kate Gilbert, David Hoffmeister, Eric Winzer, Ludwig Huber, Aaron Shatkin

Premium

MFIC announced that its microfluidics division has named William Beltz as industry marketing manager. Beltz will be responsible for the company’s Microfluidizer processors, primarily in the biotechnology and pharmaceutical sectors, MFIC said, and will also lead the launch of the company’s new high-pressure Multiple Stream Mixer Reactor for the continuous creation of nanoparticles.

Beltz has held product management and marketing positions at Applied Biosystems, Schleicher & Schuell, DuPont Biotechnology Systems, and NEN, MFIC said. He also led his own firm, Biotechnology Associates, a biotechnology consulting service.


Kate Gilbert, formerly consumables product manager at Ciphergen Biosystems, has been promoted to director of marketing, replacing Dick Rubin, who left the company in August.


David Hoffmeister has become CFO and senior vice president of Invitrogen, succeeding Eric Winzer, the Carlsbad, Calif.-based company said yesterday. He joins the company from McKinsey, where he was a senior partner. Winzer will remain part of the Invitrogen executive team.


Ludwig Huber was named compliance fellow for the life sciences and chemical analysis division of Agilent Technologies. His duties will include helping the company identify and evaluate compliance-related initiatives for pharmaceutical laboratory customers. Huber has been at Agilent and parent Hewlett Packard since 1978.


Aaron Shatkin has been elected to the board of directors of Serologicals, the company said last week. Shatkin is currently the director of the Center for Advanced Biotechnology and Medicine, as well as a professor of molecular genetics and microbiology at the Robert W. Johnson Medical School in Piscataway, NJ. He is also a professor of molecular biology at Rutgers University.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.